Hoth Therapeutics

(NASDAQ) HOTH

Current Price$0.68

Market Cap$12.24M

Since IPO (2019)-100%

5 Year-98%

1 Year-23%

1 Month-15%

Hoth Therapeutics Financials at a Glance

Market Cap

$12.24M

Revenue (TTM)

$0.00

Net Income (TTM)

$11.69M

EPS (TTM)

$-0.81

P/E Ratio

-0.79

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$0.68

Volume

5,531

Open

$0.66

Price

$0.68

Volume

5,531

Open

$0.66

Previous Close

$0.68

Daily Range

$0.64 - $0.68

52-Week Range

$0.49 - $2.12

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$0.68

Volume

5,531

Open

$0.66

Previous Close

$0.68

Daily Range

$0.64 - $0.68

52-Week Range

$0.49 - $2.12

HOTH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hoth Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Robbie Knie

Website

www.hoththerapeutics.com

Headquarters

New York City, NY 10020, US

HOTH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-149%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-1.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.24M

Shares Outstanding

19.13M

Volume

5.53K

Avg. Volume

2.68M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.11M

EBITDA

$11.11M

Operating Cash Flow

$9.80M

Capital Expenditure

$0.00

Free Cash Flow

$9.80M

Cash & ST Invst.

$6.25M

Total Debt

$5.68K

Hoth Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$12.24M

N/A

Market Cap/Employee

$6.12M

N/A

Employees

N/A

Net Income

$2.69M

+22.5%

EBITDA

$2.65M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$4.05M

-64.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.09%

N/A

Return on Invested Capital

-2.77%

N/A

Free Cash Flow

$3.05M

-9.4%

Operating Cash Flow

$3.05M

-9.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

CRISCuris, Inc.

CRISCuris, Inc.$0.50+2.29%

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$3.49-6.18%

PCSAProcessa Pharmaceuticals, Inc.

PCSAProcessa Pharmaceuticals, Inc.$2.65+5.75%

PULMPulmatrix, Inc.

PULMPulmatrix, Inc.$1.34-2.19%

FBLGFibroBiologics, Inc. Common Stock

FBLGFibroBiologics, Inc. Common Stock$1.05+0.00%

DAREDaré Bioscience, Inc.

DAREDaré Bioscience, Inc.$2.37-1.66%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

INTCIntel

INTCIntel$119.84+0.01%

ONDSOndas

ONDSOndas$9.06-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.84+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.50-0.01%

MDLNMedline

MDLNMedline$37.01-0.00%

MARAMara Holdings

MARAMara Holdings$13.81+0.02%

Questions About HOTH

What is the current price of Hoth Therapeutics?

Hoth Therapeutics is trading at $0.68 per share.

What is the 52-week range for Hoth Therapeutics?

Over the past 52 weeks, Hoth Therapeutics has traded between $0.49 and $2.12.

How much debt does Hoth Therapeutics have?

As of the most recent reporting period, Hoth Therapeutics reported total debt of N/A.

How much cash does Hoth Therapeutics have on hand?

Hoth Therapeutics reported $4.05M in cash and cash equivalents in its most recent financial results.

What is Hoth Therapeutics’s dividend yield?

Hoth Therapeutics does not currently have a dividend yield.

Hoth Therapeutics

Hoth Therapeutics Financials at a Glance

HOTH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Hoth Therapeutics

HOTH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Hoth Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HOTH

What is the current price of Hoth Therapeutics?

What is the 52-week range for Hoth Therapeutics?

How much debt does Hoth Therapeutics have?

How much cash does Hoth Therapeutics have on hand?

What is Hoth Therapeutics’s dividend yield?

Premium Investing Services